一个SARS-CoV和SARS-CoV-2 RBD异构体疫苗候选人
Rong Zhang1,2, Dedong Li2, Pengyue Gao2,3,4
1College of Animal Sciences and Veterinary Medicine, Guangxi University (GXU), Nanning, China.
Journal of medical virology
|May 3, 2025
概括
结合SARS-CoV和SARS-CoV-2受体结合域 (RBDs) 的新型异构体免疫原显示出对抗萨尔贝科病毒的广泛保护性疫苗的希望,包括新兴变种.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 由于SARS-CoV-2不断发展,因此需要广泛的保护性疫苗.
- 沙贝科病毒的动物传播构成了持续的威胁.
- 之前的研究表明,异构体RBD设计增强了交叉反应性免疫性.
研究的目的:
- 开发一种泛沙尔贝科病毒候选疫苗,使用异构体RBD策略.
- 评估开发的免疫原体对不同类型和变种的萨尔贝科病毒的交叉中和能力.
主要方法:
- 构建了一种异构体免疫原,其中包含来自SARS-CoV和SARS-CoV-2的RBD.
- 在小鼠中利用伪病毒中和试验来评估免疫性和中和抗体 (NAb) 标位.
- 开发了更新的免疫原体 (BA.1-SARS,BA.2-SARS) 来准Omicron亚型变种.
主要成果:
- 与SARS-CoV RBD同位体相比,PT-SARS异位体对SARS-CoV-2亚变体的NAb标位显著更高.
- 与SARS-CoV-2 RBD同位体相比,PT-SARS显示了对WIV1和SARS-CoV的增强中和.
- 该BA.2-SARS免疫原表现出对BA.2.86变种的中和功效有所改善.
- 异构体免疫原诱导了平衡的,广泛的NAbs对抗多种sarbecoviruses.
结论:
- 异构体RBD策略是泛沙尔贝科病毒疫苗的可行基础.
- 开发的免疫原体显示出对SARS-CoV-2变种和其他sarbecoviruses的广泛保护的潜力.
- 进一步开发这种免疫原体可以解决新出现的萨尔贝科病毒菌株的威胁.
关键词:
在RBD中,RBD是RBD.这就是SARS-CoV.在SARS-CoV-2中.广泛的频谱使用.这种异构聚合物是异构聚合物.沙贝科病毒 (Sarbecovirus) 是一种病毒.疫苗 疫苗 疫苗 疫苗更多相关视频
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.4K
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.4K
相关概念视频
01:03Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
01:14Rab Proteins
3.8K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
3.8K
00:42Cross-reactivity
30.9K
Overview
30.9K
02:50Conjugated Proteins
18.1K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.1K